StonvexLoading…
StonvexStonvexStonvexCore line items from NMIH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $183.47M | $706.44M | $525.70M | $347.02M |
Operating Income | $124.94M | $499.80M | $378.65M | $254.97M |
Net Income | $99.33M | $388.93M | $294.71M | $96.15M |
EPS (Diluted) | $1.28 | $4.92 | $3.72 | $2.50 |
Total Assets | $3.91B | $3.84B | $3.73B | $3.59B |
Total Liabilities | $1.28B | $1.25B | $1.21B | $1.17B |
Cash & Equivalents | $70.68M | $43.94M | $130.44M | $84.01M |
Free Cash Flow OCF − CapEx | $114.99M | $412.52M | $352.42M | $226.15M |
Shares Outstanding | 76.15M | 76.29M | 77.10M | 77.72M |